✦ LIBER ✦

Phase 1 Trial of High-Dose Exogenous Testosterone in Patients with Castration-Resistant Metastatic Prostate Cancer

✍ Scribed by Michael J. Morris; Daisy Huang; William K. Kelly; Susan F. Slovin; Ryan D. Stephenson; Caitlin Eicher; Anthony Delacruz; Tracy Curley; Lawrence H. Schwartz; Howard I. Scher

Book ID: 113611413
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 568 KB
Volume: 56
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2009.03.073

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Re: Phase 1 Trial of High-Dose Exogenous

Re: Phase 1 Trial of High-Dose Exogenous Testosterone in Patients with Castration-Resistant Metastatic Prostate Cancer

✍ Paul H. Lange 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 209 KB

Commentary on Phase 1 trial of high-dose

Commentary on Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate cancer: Morris MJ, Huang D, Kelly WK, Slovin SF, Stephenson RD, Eicher C, Delacruz A, Curley T, Schwartz LH, Scher HI, Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY; Weill Medical College of Cornell University, New York, NY

✍ Daniel W. Lin 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Re: Michael J. Morris, Daisy Huang, Will

Re: Michael J. Morris, Daisy Huang, William K. Kelly, et al. Phase 1 Trial of High-Dose Exogenous Testosterone in Patients with Castration-Resistant Metastatic Prostate. Eur Urol 2009;56:237–44

✍ Tomasz Drewa; Piotr Chlosta 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Ipilimumab and a poxviral vaccine target

Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

✍ Ravi A Madan; Mahsa Mohebtash; Philip M Arlen; Matteo Vergati; Myrna Rauckhorst; 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 138 KB

Combined immunotherapy with granulocyte-

Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

✍ Alfons JM van den Eertwegh; Jurjen Versluis; H Pieter van den Berg; Saskia JAM S 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 306 KB

Phase I trial with a combination of doce

Phase I trial with a combination of docetaxel and 153Sm-lexidronam in patients with castration-resistant metastatic prostate cancer

✍ Jianqing Lin; Victoria J. Sinibaldi; Michael A. Carducci; Samuel Denmeade; Danny 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 296 KB